World

UAE win FEI Endurance World Championship for Young Riders & Juniors for 4th time straight

Sep 03, 2023

Castelsagrat[France], September 3: The UAE Saturday won the FEI Endurance World Championship for Young Riders & Juniors for the 4th time straight.
The championship was held in Castelsagrat, France, and testified to the UAE team's pioneering position in the world of endurance racing. The UAE won the championship three times in a row before, in 2017, 2019, and 2021.
The victory came after a fierce competition that lasted to the final meters of the final stage. The race's entire distance was broken up into 4 stages, with the first covering 28.6 km, the second 29.2 km, the third 33.8 km, and the final 28.6 km.
Under the supervision of the International Federation for Equestrian Sports, 70 male and female riders from 25 countries competed in the event, and the victors will be crowned tomorrow, Sunday, in Castelsagrat, in the south-west of France.
Major General Dr.Mohammed Essa Aladhab, the Administrative Manager of the UAE Team , and representatives from the French and international equestrian federations attended the race.
Source: Emirates News Agency

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025